Chretien ML - Search Results

1

Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.

Atsou KM, Rachet B, Cornet E, Chretien ML, Rossi C, Remontet L, Roche L, Giorgi R, Gauthier S, Girard S, Böckle J, Wasse SK, Rachou H, Bouzid L, Poncet JM, Orazio S, Monnereau A, Troussard X, Mounier M, Maynadie M. Atsou KM, et al. Among authors: chretien ml. Cancer Med. 2023 Apr;12(7):8911-8923. doi: 10.1002/cam4.5645. Epub 2023 Jan 29. Cancer Med. 2023. PMID: 36710405 Free PMC article.

2

Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients.

Rossi C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, Humbert O, Legouge C, Chrétien ML, Bastie JN, Brunotte F, Casasnovas RO. Rossi C, et al. Among authors: chretien ml. J Nucl Med. 2014 Apr;55(4):569-73. doi: 10.2967/jnumed.113.130609. Epub 2014 Feb 24. J Nucl Med. 2014. PMID: 24566003 Free article.

3

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.

Lang AS, Mounier M, Roques M, Chretien ML, Boulin M. Lang AS, et al. Among authors: chretien ml. J Clin Pharm Ther. 2015 Aug;40(4):391-7. doi: 10.1111/jcpt.12273. Epub 2015 Apr 10. J Clin Pharm Ther. 2015. PMID: 25865674

4

Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Rossi C, Chrétien ML, Casasnovas RO. Rossi C, et al. Among authors: chretien ml. Target Oncol. 2018 Jun;13(3):287-308. doi: 10.1007/s11523-018-0558-1. Target Oncol. 2018. PMID: 29556925 Review.

5

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).

Burlet B, Ramla S, Fournier C, Abrey-Recalde MJ, Sauter C, Chrétien ML, Rossi C, Duffourd Y, Ragot S, Buriller C, Tournier B, Chapusot C, Nadal N, Racine J, Guy J, Bailly F, Martin L, Casasnovas O, Bastie JN, Caillot D, Albuisson J, Broccardo C, Thieblemont C, Delva L, Maynadié M, Aucagne R, Callanan MB. Burlet B, et al. Among authors: chretien ml. Cold Spring Harb Mol Case Stud. 2021 Feb 19;7(1):a005934. doi: 10.1101/mcs.a005934. Print 2021 Feb. Cold Spring Harb Mol Case Stud. 2021. PMID: 33608382 Free PMC article.

6

Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome.

Baumelou M, Payssot A, Row C, Racine J, Lafon I, Bastie JN, Chevreux S, Chrétien ML, Maynadié M, Caillot D, Guy J. Baumelou M, et al. Among authors: chretien ml. Br J Haematol. 2022 Jun;197(6):e82-e85. doi: 10.1111/bjh.18103. Epub 2022 Mar 11. Br J Haematol. 2022. PMID: 35277859 No abstract available.

7

Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database.

Cottin Y, Boulin M, Doisy C, Mounier M, Caillot D, Chretien ML, Bodin A, Herbert J, Bonnotte B, Zeller M, Maynadié M, Fauchier L. Cottin Y, et al. Among authors: chretien ml. Cancers (Basel). 2022 Jun 21;14(13):3049. doi: 10.3390/cancers14133049. Cancers (Basel). 2022. PMID: 35804821 Free PMC article.

8

Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients.

Girodon F, Dutrillaux F, Broséus J, Mounier M, Goussot V, Bardonnaud P, Chrétien ML, Maynadié M. Girodon F, et al. Among authors: chretien ml. Leukemia. 2010 Apr;24(4):900-3. doi: 10.1038/leu.2010.5. Epub 2010 Feb 4. Leukemia. 2010. PMID: 20130601 No abstract available.

9

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation.

Fouquet G, Hebraud B, Garciaz S, Stoppa AM, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Touzeau C, Tessoulin B, Fermand JP, Facon T, Attal M, Loiseau HA, Moreau P, Leleu X. Fouquet G, et al. Among authors: chretien ml. J Cancer. 2014 Mar 11;5(3):248-52. doi: 10.7150/jca.8541. eCollection 2014. J Cancer. 2014. PMID: 24665349 Free PMC article.

10

Self-management of immunomodulatory drug treatment in multiple myeloma patients.

Cransac A, Aho S, Cosme E, Chretien ML, Favennec C, Schreder L, Boutet M, Gueneau P, Giroud M, Caillot D, Boulin M. Cransac A, et al. Among authors: chretien ml. Eur J Cancer Care (Engl). 2021 Jan;30(1):e13356. doi: 10.1111/ecc.13356. Epub 2020 Nov 6. Eur J Cancer Care (Engl). 2021. PMID: 33159353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page